In India, China and several other nations, Novo Nordisk is on the verge of losing patent protection for its blockbuster weight loss drug, opening the door for cheaper competing versions.
Source link
Related Posts
Subscribe to Updates
Get the latest creative news from FooBar about art, design and business.
© 2026 The Politics Designed by The Politics.
